Clinical Data on Exactech Technologies for Shoulder, Knee and Ankle Replacement Surgery Presented at the 2015 Orthopaedic Research Society Annual Meeting

GAINESVILLE, Fla.--()--Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, extremities, spine and biologic materials, presented scientific posters and presentations regarding its latest advancements for shoulder, knee and ankle replacement surgery during the 2015 Orthopaedic Research Society (ORS) annual meeting in Las Vegas.

Two posters discussed computer-assisted orthopaedic surgery with ExactechGPS® Guided Personalized Surgery, a surgeon-controlled, real-time, patient-specific technology for reproducibility and efficiency in total knee arthroplasty:

  • Angibaud, L. et al. Effects of Repetitive Training Practices Using an Image-Free Computer-Assisted Guidance System on Cognitive and Technical Skills Trans. of the 61st Annual ORS Meeting, Poster #1819, 2015.
  • Angibaud, L. et al. Evaluation of Bone Deformity on Alignment Discrepancies During Total Knee Arthroplasty Using an Image-Free Computer-Assisted Guidance System. Trans. of the 61st Annual ORS Meeting, Poster #1820, 2015.

Four posters presented the biomechanical advantages of Exactech’s Equinoxe® shoulder system, the fastest growing shoulder replacement system in the United States1:

  • Roche, C. et al. Optimizing Deltoid Efficiency with Reverse Shoulder Arthroplasty Using a Novel Glenosphere Geometry. Trans. of the 61st Annual ORS Meeting, Poster #1011, 2015.
  • Roche, C et al. A Comparison and Correlation of Clinical Outcome Metrics in Anatomic and Reverse Total Shoulder Arthroplasty. Trans. of the 61st Annual ORS Meeting, Poster #2023, 2015.
  • Jacobson, A. et al. Glenohumeral Anatomy Study: A Comparison of Male and Female Shoulders with Similar Average Age and BMI. Trans. of the 61st Annual ORS Meeting, Poster #1842, 2015.
  • Roche, C. et al. Impact of Humeral Offset on Muscle Length with Reverse Shoulder Arthroplasty. Trans. of the 61st Annual ORS Meeting, Poster # 1863, 2015.

An Exactech poster that highlighted foot and ankle reconstruction was chosen by the ORS as one of the “Best of the ORS” in its category:

  • Hamilton, M. et al. Predicting Tibial Stress Fields Around Total Ankle Replacements. Trans. of the 61st Annual ORS Meeting, Poster # 1902, 2015.

Two posters studied a process related to cartilage repair:

  • Lee, P. et al. Measurement Of Residual Enzyme And Enzyme Penetration Depth In Partially Digested Cartilage Tissue. Trans. of the 61st Annual ORS Meeting, Poster #1265, 2015.
  • McNally, A. et al. Enzymatically Treated Adult Cartilage Fragments for Cartilage Regeneration: Is Fibrin Glue Appropriate for Cartilage Repair? Trans. of the 61st Annual ORS Meeting, Poster #377, 2015.

About Exactech

Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, as well as more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech, Inc. can be found at http://www.exac.com. Copies of Exactech’s press releases, SEC filings, current price quotes and other valuable information for investors may be found at http://www.exac.com and http://www.hawkassociates.com.

An investment profile on Exactech may be found at http://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at http://www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

References

1. Global Data. Total Shoulder Replacement – Global Analysis and Market Forecasts. June 2013.

Contacts

Exactech Inc.
Investor contacts
Jody Phillips, 352-377-1140
Executive Vice President of Finance &
Chief Financial Officer
or
Hawk Associates
Julie Marshall or Frank Hawkins, 305-451-1888
E-mail: EXAC@hawkassociates.com
or
Exactech Inc.
Media contact
Priscilla Bennett, 352-377-1140
Vice President, Corporate & Marketing Communication

Contacts

Exactech Inc.
Investor contacts
Jody Phillips, 352-377-1140
Executive Vice President of Finance &
Chief Financial Officer
or
Hawk Associates
Julie Marshall or Frank Hawkins, 305-451-1888
E-mail: EXAC@hawkassociates.com
or
Exactech Inc.
Media contact
Priscilla Bennett, 352-377-1140
Vice President, Corporate & Marketing Communication